Ohio Administrative Code
Title 3701 - Department of Health - Administration and Director
Chapter 3701-55 - Newborn Screening for Genetic, Endocrine, or Metabolic Disorders
Section 3701-55-04 - Notification prior to screening
Current through all regulations passed and filed through September 16, 2024
(A) Prior to collecting the blood specimen for screening, the person designated in the applicable provision of this rule will give each newborn child's parent, legal guardian, or legal custodian, notice of the screening to be conducted by providing printed information describing the newborn genetic, endocrine and metabolic screening program.
(B) For purposes of screening for krabbe disease, the designated person as listed in paragraph (A) of this rule will provide information to the parent, legal guardian, or legal custodian of their right to forgo the screening. If the parent, legal guardian, or legal custodian communicates the decision to forgo this screening, the designated person must document and submit this response to the bureau of public health laboratory in a manner prescribed by the director.
(C) The director will provide the printed information required by this rule to hospitals, freestanding birthing centers, health commissioners, physicians, certified nurse midwives, certified nurse practitioners and clinical nurse specialists.
(D) The director will conduct educational programs for hospital and freestanding birthing center newborn screening coordinators, physicians, certified nurse midwives, certified nurse practitioners and clinical nurse specialists, nurses, laboratory staff and others involved in the collection and follow-up of newborn screening specimens.